ID: ALA3087938

Max Phase: Preclinical

Molecular Formula: C16H15F2N3O6P2S

Molecular Weight: 477.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=P(O)(O)C(Nc1ncnc2sc(-c3ccc(C4CC4(F)F)cc3)cc12)P(=O)(O)O

Standard InChI:  InChI=1S/C16H15F2N3O6P2S/c17-16(18)6-11(16)8-1-3-9(4-2-8)12-5-10-13(19-7-20-14(10)30-12)21-15(28(22,23)24)29(25,26)27/h1-5,7,11,15H,6H2,(H,19,20,21)(H2,22,23,24)(H2,25,26,27)

Standard InChI Key:  VVDXYOLRKZUNHL-UHFFFAOYSA-N

Associated Targets(Human)

Geranylgeranyl pyrophosphate synthetase 715 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Farnesyl diphosphate synthase 1240 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 477.32Molecular Weight (Monoisotopic): 477.0125AlogP: 3.53#Rotatable Bonds: 6
Polar Surface Area: 152.87Molecular Species: ACIDHBA: 6HBD: 5
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 0.89CX Basic pKa: 3.83CX LogP: 0.07CX LogD: -2.79
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.34Np Likeness Score: -0.65

References

1. Leung CY, Park J, De Schutter JW, Sebag M, Berghuis AM, Tsantrizos YS..  (2013)  Thienopyrimidine bisphosphonate (ThPBP) inhibitors of the human farnesyl pyrophosphate synthase: optimization and characterization of the mode of inhibition.,  56  (20): [PMID:23998921] [10.1021/jm400946f]

Source